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Perinatal asphyxia (PA) is responsible for a large proportion of neonatal deaths and
numerous neurological sequelae, including visual dysfunction and blindness. In PA,
the retina is exposed to ischemia/reoxygenation, which results in nitric oxide (NO)
overproduction and neurotoxicity. We hypothesized that methylene blue (MB), a guanylyl
cyclase inhibitor, and free-radical scavenger currently used in the clinic, may block this
pathway and prevent PA-induced retinal degeneration. Male rat pups were subjected
to an experimental model of PA. Four groups were studied: normally delivered (CTL),
normally delivered treated with 2 mg Kg-1 MB (MB), exposed to PA for 20 min
at 37◦C (PA), and exposed to PA and, then, treated with MB (PA-MB). Scotopic
electroretinography performed 45 days after birth showed that PA animals had significant
defects in the a- and b-waves and oscillatory potentials (OP). The same animals
presented a significant increase in the thickness of the inner retina and a large
number of TUNEL-positive cells. All these physiological and morphological parameters
were significantly prevented by the treatment with MB. Gene expression analysis
demonstrated significant increases in iNOS, MMP9, and VEGF in the eyes of PA animals,
which were prevented by MB treatment. In conclusion, MB regulates key players of
inflammation, matrix remodeling, gliosis, and angiogenesis in the eye and could be used
as a treatment to prevent the deleterious visual consequences of PA. Given its safety
profile and low cost, MB may be used clinically in places where alternative treatments
may be unavailable.
Keywords: angiogenesis, apoptosis, electroretinography, inner retinal thickness, methylene blue,
perinatal asphyxia
INTRODUCTION
Perinatal asphyxia (PA) is the most severe perinatological problem across the world (World Health
Organization, 1991) and is associated with approximately one-quarter of global neonatal deaths (Liu
et al., 2015). PA generates a transient global ischemic status which could damage the central nervous
system, including the retina (Ferriero, 2004). Depending on the length and intensity of the ischemic
episode, PA sequelae may include attention-deficit hyperactivity disorder, spasticity, epilepsy,
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mental retardation (Herrera et al., 2018), and hearing or visual
dysfunctions, including blindness (Hill, 1991). In 2010, there
were an estimated 1.15 million cases of neonatal encephalopathy,
of which 96% were from low- and middle-income countries
(Mukhtar-Yola et al., 2018). Therapeutic hypothermia is
currently the standard of care for newborns exposed to PA
(Rivero-Arias et al., 2019), but this treatment may require
expensive devices to be properly applied (Dingley et al., 2015)
that could be prohibitive for some developing regions of the
world. Our long-term goal is to investigate and promote the
use of safe and affordable drugs in the prevention of visual loss
associated with PA.
Exposure of the retina to hypoxia/ischemia-reoxygenation
induces the expression of hypoxia-inducible factor-1α (HIF1α)
and its target genes such as vascular endothelial growth factor
(VEGF), adrenomedullin (AM), and inducible nitric oxide
synthase (iNOS), among others (Rey-Funes et al., 2011). VEGF
and AM are angiogenic factors that contribute to the thickening
of the inner layers of the retina (Rey-Funes et al., 2013), whereas
iNOS produces nitric oxide (NO) which reacts with the free
radical superoxide resulting in elevated levels of peroxynitrites
and extensive protein nitration, leading to neuronal cell death
(Rodrigo et al., 2005). Excessive NO formation induces cytotoxic
effects in the retina and is postulated as a key neurotoxic factor
in retinal ischemia (Osborne et al., 2004). Therefore, inhibitors of
NO activity may constitute valuable drugs for preventing retinal
damage in the context of PA.
Most physiological actions of NO are mediated by the
formation of the second messenger cGMP, which is produced
by the action of guanylyl cyclase (Ding and Weinberg, 2007).
Methylene blue (MB) is a guanylyl cyclase inhibitor (Hwang
et al., 1998) which is also able to inhibit NADPH oxidase
and myeloperoxidase enzymes (Heydrick et al., 2007) by either
acting as a free radical scavenger or competing for oxygen
(Atamna et al., 2008). MB exhibits a high safety profile
(Bewick and Pfleiderer, 2014; Landoni et al., 2014) and is
approved for clinical use as an antidote of poison-induced
methemoglobinemia (Wright et al., 1999), in norepinephrine-
refractory hypotension (Sparicio et al., 2004), and for the
surgical management of hyperparathyroidism (Bewick and
Pfleiderer, 2014), among others. MB is on the World Health
Organization’s List of Essential Medicines, the most effective
and safe medicines needed in a health system (World Health
Organization, 2017). Also, MB has been shown to prevent
retinal damage induced by rotenone (Zhang et al., 2006) or
optic neuropathy (Rojas et al., 2009) in animal models. In a
previous article, we showed that MB was able to significantly
reduce morphological and molecular hallmarks of retinal damage
caused by PA when applied preventively to the pregnant
dams before delivery (Rey-Funes et al., 2016). The risks of
suffering PA are well known (Martinez-Biarge et al., 2013)
and the application of MB to high-risk mothers may reduce
vision loss in their children. Nevertheless, we understand that
an efficacious treatment that is applied after PA has been
diagnosed would be better received by patients and the medical
staff. In consequence, this report aimed to demonstrate the
beneficial effects of treating asphyctic newborns with MB




Severe PA was induced using a noninvasive model of hypoxia-
ischemia as described (Loidl et al., 2000). Sprague–Dawley albino
rats with genetic quality and sanitary certification from the
animal facility of our Institution were cared for following the
guidelines published in the ARVO Statement for the Use of
Animals in Ophthalmic and Vision Research. The procedures
described below were approved by the Ethical Committee of
CICUAL (Comité Institucional para el Uso y Cuidado de
Animales de Laboratorio, Resolution N◦ 2079/07), Facultad de
Medicina, Universidad de Buenos Aires, Argentina. Appropriate
proceedings were performed to minimize the number of animals
used and their suffering, pain, and discomfort. Animals were kept
under standard laboratory conditions at 24◦C, with light/dark
cycles of 12/12 h, and food and water were provided ad libitum.
Thirty timed-pregnant Sprague–Dawley rats were sacrificed
by decapitation and immediately hysterectomized after their
first pups were delivered vaginally. These normally delivered,
non-manipulated pups were used as controls. Full-term fetuses,
still inside the uterus, were subjected to asphyxia performed
by transient immersion of both uterine horns in a water bath
for 20 min at 37◦C. After asphyxia, the uterine horns were
opened, pups were removed, dried of delivery fluids, stimulated
to breathe, and their umbilical cords were ligated. Pups were then
placed for recovery under a heating lamp and given to surrogate
mothers. To avoid the influence of hormonal variations due to
the female estrous cycle, only male pups were included in this
study. One hour after birth, control newborns were randomly
divided into two groups, which received a 50 µl subcutaneous
injection of either saline solution (CTL group, n = 30) or a
dose of 2 mg Kg−1 methylene blue in saline solution (Sigma,
St. Louis, MO, USA; MB group, n = 30). The same procedure
was implemented with asphyctic newborns to generate the other
two experimental groups: asphyctic animals that received saline
(PA group, n = 30) or methylene blue treatment (PA-MB group,
n = 30).
Electroretinograms
Forty-five days after birth, young rats (n = 10 per experimental
group) were subjected to scotopic electroretinography, as
described (Rey-Funes et al., 2017). Briefly, after overnight
adaptation in the dark, rats were anesthetized with 40 mg/Kg
ketamine (Ketamine 50r, Holiday-Scott SA, Beccar, Argentina)
+ 5 mg/Kg xylazine (Kensolr, Laboratorios Köning SA,
Buenos Aires, Argentina) under dim red illumination. An
ophthalmic solution of 5% phenylephrine hydrochloride and
0.5% tropicamide (Fotorretin, Poen, Buenos Aires, Argentina)
was used to dilate the pupils. Rats were placed facing the stimulus
at a distance of 25 cm in a highly reflective environment. A
reference electrode was placed through the ear, a grounding
electrode was attached to the tail, and a gold electrode was placed
in contact with the central cornea. Scotopic electroretinograms
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TABLE 1 | Antibodies used in this study.
Primary antibodies
Target Species Dilution Source Reference
GFAP Rabbit polyclonal 1:500 Dako Z0334
HNEJ-2 Mouse monoclonal 1:25 Abcam ab48506
8-OHdG Mouse monoclonal 1:50 Santa Cruz sc-66036
Secondary antibodies
Specificity Label Dilution Source Reference
Donkey anti-rabbit Alexa Fluorr 555 1:200 Invitrogen A31572
Donkey anti-mouse Alexa Fluorr 488 1:600 Invitrogen A21202
(ERG) were recorded from both eyes simultaneously and
20 responses were collected to flashes of unattenuated white light
(1 ms, 1 Hz) from a photic stimulator (light-emitting diodes) set
at maximum brightness. The registered response was amplified
(9 cd s/m2 without filter), filtered (1.5-Hz low-pass filter, 500 Hz
high-pass filter, notch activated), and averaged (Akonic BIO-
PC, Buenos Aires, Argentina). The a-wave was measured as the
difference in amplitude between the recording at onset and the
trough of the negative deflection and the b-wave amplitude was
measured from the trough of the a-wave to the peak of the b-
wave. Values from each eye were averaged, and the resultant
mean value was used to compute the group’s mean a- and b-wave
amplitudes ± SEM. To calculate oscillatory potentials (OP), the
same photic stimulator was used with filters of high (300 Hz)
and low (100 Hz) frequency. The amplitudes of the OP were
estimated by using the peak-to-trough method. The sum of three
OP was used for statistical analysis.
Tissue Processing, Histology, and TUNEL
Rats on the four experimental groups were sacrificed 6 days
postpartum (n = 4 per experimental group). Animals were
decapitated. After enucleating, anterior segments of the
eyes, including the lens, were discarded, and the posterior
segments of the eyes containing the retinas were fixed in 4%
paraformaldehyde in 0.1 M pH 7.4 phosphate buffer at 4◦C for
48 h. Tissues were dehydrated and paraffin-embedded. Tissue
sections (5 µm-thick) were stained for terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) with the in situ Cell
Death Detection POD Kit (Roche, Basel, Switzerland), following
manufacturer’s instructions. Visualization of immunoreactivity
was performed with 0.03% 3,3′diaminobenzidine (Sigma Co, St.
Louis, MO, USA), 3% nickel ammonium sulphate and 0.01%
hydrogen peroxide diluted in 0.1 M buffer acetate, yielding a
black product.
The animals used for electroretinography were
intraperitoneally anesthetized with ketamine/xylazine and
intracardially perfused with the same fixative. The posterior
segments of the eyes were paraffin-embedded, sectioned, and
stained with hematoxylin-eosin to count the number of ganglion
cells and to measure the thickness of the most inner layers of the
retina (IR), which includes the internal limiting membrane, the
retinal optic nerve fiber layer, and the ganglion cell layer (GCL),
as reported (Rey-Funes et al., 2013).
Immunofluorescence and Confocal
Microscopy
Additional tissue sections were dewaxed, rehydrated, and
subjected to antigen retrieval (10 mM sodium citrate, 0.5%
Tween 20, pH 6.0, 30 min at 95◦C). Non-specific binding
was blocked by exposure to 10% normal donkey serum
(Jackson Immunoresearch Laboratories, West Grove, PA, USA)
for 30 min, and then tissue sections were incubated with
primary antibodies (Table 1), overnight at 4◦C. The following
day, the presence of the primary antibody was detected by
incubation with fluorescent secondary antibodies (Table 1) and
counterstained with DAPI (Molecular Probes, Eugene, OR,
USA). These slides were analyzed with a confocal microscope
(TCS SP5, Leica, Badalona, Spain).
Image Analysis
The eyes of four animals of each experimental group were
analyzed. Care was taken on selecting anatomically matched
areas of retina among animals before assays. The central area
of the sagittal plane was chosen for each retina. The thickness
of all layers in the retina was measured in 10 fields using Scion
Image software. Special attention was paid to the inner retina
(IR), which includes the internal limiting membrane, the optic
retinal nerve fiber layer, and the GCL.
TUNEL-positive cells were counted on the retinas of four eyes
per experimental group. Fields were chosen in the central region
of retinal cross-sections and the number of positive cells in ten
fields, 500 µm in length, was recorded.
RNA Extraction and Quantitative
Real-Time PCR
Animals from all experimental groups (n = 4 per experimental
group) were sacrificed at different times after MB treatment (4, 6,
12, 24 h). The posterior chambers of the eyes were homogenized
with TRIzol (Invitrogen, Madrid, Spain) and RNA was isolated
with RNeasy Mini kit including a DNAse I on-column digestion
(Qiagen, Germantown, MD, USA). One microgram of total RNA
was reverse-transcribed into first-strand cDNA using random
primers and the SuperScript III kit (Invitrogen) in a total volume
of 20 µl according to the manufacturer’s instructions. Reverse
transcriptase was omitted in control reactions, where the absence
of PCR-amplified DNA confirmed the lack of contamination
from genomic DNA. Resulting cDNA was mixed with SYBR
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Green PCR Master Mix (Applied Biosystems, Carlsbad, CA,
USA) for quantitative real-time polymerase chain reaction
(qRT-PCR) using 0.3 µM forward and reverse oligonucleotide
primers (Table 2). Quantitative measures were performed using
a 7300 Real-Time PCR System (Applied Biosystems). Cycling
conditions were an initial denaturation at 95◦C for 10 min,
followed by 40 cycles of 95◦C for 15 s and 60◦C for 1 min.
In the end, a dissociation curve was implemented from 60 to
95◦C to validate amplicon specificity. Gene expression was
calculated using relative quantification by interpolation into a
standard curve. All values were divided by the expression of the
housekeeping gene 18S.
Statistical Analysis
All data were analyzed with GraphPad Prism 5 software and
were considered statistically significant when p < 0.05. Values
are expressed as means ± SEM. Normally distributed data
were evaluated by ANOVA followed by either Holm-Sidak or
Newman–Keuls post hoc test.
RESULTS
MB Treatment Prevents Asphyxia-Induced
Modifications of the a- and b-Waves and
the Oscillatory Potentials of the
Electroretinogram
Animals were divided into four experimental groups and
treated as explained in the ‘‘Materials and Methods’’ section.
The overall mortality rate for the asphyctic group was 40%,
similar to previous reports (Loidl et al., 2000). Injection of
MB, a well-known dye (Li et al., 2018), left a blue area
under the skin of treated animals but this stain disappeared
2 or 3 days after injection. Scotopic ERG performed 45 days
after birth showed that those animals that had suffered
PA had a significant (p < 0.001) reduction of the a-
and b-wave amplitude (Figures 1C,E, 2C,E) compared to
those who were born uneventfully (Figures 1A,E, 2A,E).
Treatment of the control animals with MB resulted in a
mild reduction (p < 0.05) in the amplitude of both waves
(Figures 1B,E, 2B,E). Notably, MB treatment of asphyctic
pups resulted in a- (p < 0.05) and b- (p < 0.001) waves
TABLE 2 | Primers used for quantitative real-time polymerase chain reaction
(qRT-PCR) in this study.
Target
gene










The annealing temperature was 60◦C for all primers. 18S was used as a
housekeeping gene.
more similar to the controls than to the PA animals
(Figures 1D,E, 2D,E).
Similar observations were made when studying the
OP (Figure 3). PA-induced a strong loss of complexity
(p < 0.0001) in the OP patterns (Figures 3C,E) whereas MB
treatment significantly (p < 0.001) restored the control pattern
(Figures 3D,E).
MB Treatment Reduces Asphyxia-Induced
Thickening of the Inner Retina and GFAP
Immunoreactivity
It has been previously reported that PA results in morphological
changes of the retina, including a thicker inner retina (IR), and
an increased number of GFAP-positive cellular processes (Rey-
Funes et al., 2016). This was also the case in the present study.
The eyes of the PA group had a significantly (p < 0.0001)
thicker IR (Figures 4C,E) than those of the CTL group
(Figures 4A,E). Treatment of the control newborns with MB
did not change this parameter (Figures 4B,E) but the treatment
of the asphyctic pups significantly (p < 0.0001) prevented this
morphological manifestation of the pathology (Figures 4D,E).
The thickness of all other layers of the retina was measured
and compared but no statistically significant differences were
found among experimental groups (results not shown). The
number of ganglion cells in a specified length (500 µm)
was also compared among experimental groups (Figure 4F).
There was a very significant reduction in the number of
ganglion cells in the PA animals (p < 0.0001) compared to the
control groups. In the PA-MB group, the number of ganglion
cells was significantly higher (p < 0.0001) than in the PA
group (Figure 4F).
Furthermore, GFAP immunostaining showed a marked
increase in GFAP signal in the PA group (Figure 5C)
compared with either the CTL (Figure 5A) or MB
(Figure 5B) groups. Application of MB (Figure 5D) reduced
GFAP expression to levels similar to those observed in
the controls.
MB Treatment Reduces Asphyxia-Induced
Apoptosis in the Ganglion Cell Layer
TUNEL analysis of the retinas (Figure 6) showed that exposure
to PA results in a very significant (p < 0.0001) increase in the
number of apoptotic cells (arrows) in the GCL (Figures 6C,E),
whereas control animals have a very low number of labeled
cells (Figures 6A,E). Postnatal treatment with MB significantly
(p < 0.0001) reduced the number of apoptotic cells in the retina
of asphyctic animals (Figures 6D,E) whereas it had no significant
effect on non-asphyctic retinas (Figures 6B,E). A large number
of apoptotic cells was observed among the neuroblasts that
would develop into the inner (black arrowheads in Figure 6C)
and outer (white arrowheads in Figure 6C) nuclear layers of
the retina of PA animals. These were not seen in control
animals (Figures 6A,B) and were very scarce in MB-treated rats
(Figure 6D).
Also, retina sections were exposed to antibodies against
4-hydroxynonenal (HNEJ-2; Figures 7A–D) and 8-hydroxy-
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FIGURE 1 | Representative scotopic electroretinograms (ERG) showing the a-waves on the four experimental groups: CTL (A), methylene blue (MB; B), perinatal
asphyxia (PA; C), and PA-MB (D). The response of the right eye is represented by red lines and that of the left one by blue lines. Quantification of the a-wave
amplitude, relativized to the CTL group, is represented as a histogram (E). Bars represent the mean ± SEM of all samples (n = 10 animals per group). Asterisks
represent statistically significant differences. *p < 0.05; ***p < 0.001. Statistical test: ANOVA followed by Holm-Sidak post hoc test.
FIGURE 2 | Representative scotopic ERG showing the b-waves on the four experimental groups: CTL (A), MB (B), PA (C), and PA-MB (D). The response of the
right eye is represented by red lines and that of the left one by blue lines. Quantification of the b-wave amplitude, relativized to the CTL group, is represented as a
histogram (E). Bars represent the mean ± SEM of all samples (n = 10 animals per group). Asterisks represent statistically significant differences. *p < 0.05;
***p < 0.001. Statistical test: ANOVA followed by Holm-Sidak post hoc test.
2’-deoxyguanosine (8-OHdG; Figures 7E–H) to further study
tissue damage due to asphyxia. For both markers, there was a
signal increase in the retinas of the PA group (Figures 7C,G)
when compared to the CTL (Figures 7A,E) and the MB group
(Figures 7B,F). Also, in both cases, the application of MB
post-asphyxia resulted in a decrease in the damage markers
(Figures 7D,H).
MB Treatment Modulates Gene Expression
of Key Players in Inflammation, Gliosis,
Matrix Remodeling, and Angiogenesis
Gene expression was studied in the retina for several markers
(Table 2) at different times after MB injection. There was a
clear time-specific modulation that was different for each gene.
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FIGURE 3 | Representative scotopic ERG showing the oscillatory potentials (OP) on the four experimental groups: CTL (A), MB (B), PA (C), and PA-MB (D). The
response of the right eye is represented by a red line and that of the left one by a blue line. Quantification of the relative OP sums, relativized to the CTL group, is
represented as a histogram (E). Bars represent the mean ± SEM of all samples (n = 10 animals per group). Asterisks represent statistically significant differences.
***p < 0.001; ****p < 0.0001. Statistical test: ANOVA followed by Holm-Sidak post hoc test.
FIGURE 4 | Representative histological images of the retina of animals of the four experimental groups: CTL (A) MB (B), PA (C), and PA-MB (D) taken 45 days after
birth. Three layers of the retina are labeled in the pictures for reference: outer nuclear layer (ONL), inner nuclear layer (INL), and ganglion cell layer (GCL). The thick
black bar demarcates the inner retina (IR). Horizontal bar = 50 µm. Quantification of the IR thickness (E) and the number of ganglion cells per 500 µm (F) are shown
as histograms. Bars represent the mean ± SEM of all samples (n = 4 animals per group, five measurements per animal). Asterisks represent statistically significant
differences, ****p < 0.0001. Statistical test: ANOVA followed by Holm-Sidak post hoc test.
The earliest significant change occurred for iNOS expression
(Figure 8A). At 4 h after treatment, there was a significant
(p < 0.05) increase of iNOS in the PA animals when compared
to CTL and MB groups. Treatment of PA animals with MB
completely prevented iNOS overexpression (p < 0.05). Other
inflammation markers whose expression was modulated by MB
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FIGURE 5 | Representative confocal microscopy images, labeled for GFAP (red), of the retina of animals of the four experimental groups: CTL (A), MB (B), PA (C),
and PA-MB (D), taken 45 days after birth. Three layers of the retina are labeled in the pictures for reference: ONL, INL, and GCL. Nuclei are counterstained with DAPI
(blue). GFAP staining is more intense in the PA group than in all the others. Horizontal bar = 50 µm.
included IL1β at 12 h (Figure 8B) and TNFα at 24 h (Figure 8C).
In both cases, there was no significant increase of expression
in the PA group over controls but there was a significant
(p < 0.05) decrease in the PA-MB group when compared to the
PA animals.
Matrix metalloproteinases (MMP) are key enzymes on tissue
remodeling. We did not see any significant modulation of
MMP2 at any time by either asphyxia or MB treatment
(Figure 8D). On the other hand, MMP9 expression was
significantly (p < 0.05) increased on the PA group at 12 h and
this pathological increase was fully prevented (p < 0.05) by MB
treatment (Figure 8E). Coinciding with these MMP9 changes, we
also found a significant decrease of GFAP expression, a marker of
gliosis, on the PA-MB group when compared to the PA animals
at 12 h (Figure 8F).
Increased angiogenesis is a typical response to
hypoxia/ischemia in the retina (Rey-Funes et al., 2013) and
we studied the expression of a positive regulator, VEGF, and
a negative regulator of angiogenesis, PEDF. At 6 h there was
a significant (p < 0.05) increase of VEGF expression in the
retinas of asphyctic rats, and this increase was significantly
counteracted (p < 0.05) by MB treatment (Figure 8G). Also,
although the expression of PEDF did not change in the PA
group, there was a very significant (p < 0.001) increase in the
PA-MB group when compared to all other experimental groups
(Figure 8H). This PEDF behavior was observed both at 6 h and
at 24 h.
DISCUSSION
In this study, we have shown that MB applied to newborns
that have suffered PA has very significant advantages in retinal
electrophysiology, morphological markers of retinal pathology,
and gene expression modulation, suggesting that this treatment
may be useful in preventing retinal damage and visual loss
associated to PA.
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FIGURE 6 | TUNEL positive cells in the four experimental groups 6 days post-treatment. Representative images of retinas from CTL (A), MB (B), PA (C), and
PA-MB (D) animals. TUNEL positive cells were found mainly in the GCL (arrows), in the precursors of the INL (black arrowheads), and of the ONL (white arrowheads).
Bar = 20 µm. Quantification of the results is shown as a histogram (E). Bars represent the mean ± SEM of all samples (n = 4 animals per group, five measurements
per animal). Asterisks represent statistically significant differences, ****p < 0.0001. Statistical test: ANOVA followed by Holm-Sidak post hoc test.
FIGURE 7 | Representative confocal microscopy images, labeled in green for HNEJ-2 (A–D) or 8-OHdG (E–H), of the retina of animals of the four experimental
groups: CTL (A,E), MB (B,F), PA (C,G), and PA-MB (D,H), taken 6 days after birth. Two layers of the retina are labeled in the pictures for reference: nuclear layer (NL;
animals are too young to distinguish the ONL and the INL yet), and GCL. Nuclei are counterstained with DAPI (blue). Increased staining is found for both HNEJ-2 and
8-OHdG in the PA samples compared to the other groups. Horizontal bar = 100 µm.
This study follows our previous work where we showed
that MB injected into pregnant dams before delivery had
a beneficial impact on the retinal health of the newborns
(Rey-Funes et al., 2016). However, although the risks for
developing PA are well known (Martinez-Biarge et al., 2013;
Bogdanovic et al., 2014), it is difficult to convince the mothers
and the medical staff to apply a preventative treatment just
before delivery. Our current data show that MB treatment
is, at least, as efficient when applied to newborns a few
hours after delivery, once the asphyxia episode has occurred
and it is evident to everyone involved that an intervention
is needed.
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FIGURE 8 | Relative gene expression in the retina of the four experimental groups for iNOS (A), IL1β (B), TNFα (C), MMP2 (D), MMP9 (E), GFAP (F), VEGF (G), and
PEDF (H). Samples were collected at the indicated times after treatment. All data represent the quotient between the gene of interest and the expression of the
housekeeping gene 18S. Bars represent the mean ± SEM of all measurements (n = 6–8). Asterisks represent statistically significant differences as indicated.
*p < 0.05, **p < 0.01; ***p < 0.001. Statistical test: ANOVA followed by the Newman–Keuls post hoc test.
Scotopic ERG showed that PA resulted in a significant
reduction of the amplitude for both a- and b-waves, as well
as a loss of complexity in the OP patterns. It is recognized
that the a-wave is generated by the photoreceptors, the OP
by the cells in the inner nuclear layer (INL), and the b-wave
by the ganglion cells (Jung et al., 2015; Matei et al., 2020;
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Zhai et al., 2020). Different animal models of retinal damage
influence ERG in a model-specific fashion. For instance, models
of blunt ocular trauma (Blanch et al., 2014) or chemical
intoxication (Chen et al., 2013) induce photoreceptor apoptosis
and a-wave disruption. Conversely, ischemic retinopathy models
(Osborne et al., 2004) or optic nerve injury (Rey-Funes et al.,
2017) are characterized by impaired inner retinal function,
showing changes in the b-wave. Therefore, we can conclude
that PA affects all the components of the retinal visual axis.
This was confirmed by the observation of TUNEL-positive
cells in the three anatomical demarcations in the retina and
overexpression of the damage markers NHEJ-2 and 8-OHdG
in rats exposed to PA. Interestingly, the application of MB
was able to normalize the physiological patterns as well as the
morphological telltales of retinal pathology, indicating that this
could constitute a new treatment to prevent visual loss in children
affected by PA.
A common morphological feature observed in all models
of ocular hypoxia/ischemia-reperfusion is the thickening of the
inner layer of the retina due to a pathological increase in gliosis
and angiogenesis (Rey-Funes et al., 2013; Luo et al., 2018).
Gliosis is due to a proliferation of the GFAP-positive processes
of Müller cells (Pekny et al., 2014) whereas the excessive number
of blood vessels reflects a lost balance between proangiogenic and
antiangiogenic factors within the eye environment (Friedlander,
2007). In the present study, both the immunoreactivity and
RNA expression of GFAP was significantly downregulated by
the treatment with MB. The proliferation of reactive astrocytes,
or Müller cells in the case of the retina, is considered an
obstacle for the proper physiological communication among
neighboring neurons (Pekny et al., 2014), so we can consider
that it may contribute to the compromised electrophysiological
recordings we found in PA animals and, perhaps, to the excessive
apoptosis of ganglion cells detected by direct counting and
corroborated by TUNEL. The contribution of MB treatment to
the reduction of retinal gliosis can thus be considered a very
desirable outcome.
Our initial hypothesis was that MB can modulate NO
production and function in the eye and, as a consequence,
could provide neuroprotection for ischemic injuries of the retina,
including PA. Our qRT-PCR results confirm this hypothesis
and show a fast expression of the inducible form of NOS just
4 h after PA, which was prevented by MB. iNOS is a Ca2+
independent isoform of NOS whose expression rises rapidly in
response to inflammatory signals and other injuries, including
ischemia-reperfusion of the retina (Rodrigo et al., 2005). iNOS
produces large amounts of NO which acts as a free radical and
contributes to tissue damage (Toda and Nakanishi-Toda, 2007).
The complete blocking of iNOS induction by MB treatment
points to a mechanistic explanation for the beneficial effects
of MB on preserving retinal function even after suffering
the ischemic insult. Other inflammatory mediators that are
regulated by MB are IL1β and TNFα. The mechanism by
which MB reduces expression of these inflammatory markers
is unknown but it may follow the earlier lowering on iNOS
expression and a general reduction on the inflammatory milieu
of the eye.
Eye angiogenesis must be very tightly controlled to avoid
pathological blood vessel overproduction, which is the cause of
many retinal and choroidal chronic diseases (Lau et al., 2018).
The main proangiogenic factor of the eye is VEGF (Virgili
et al., 2018) whereas the major antiangiogenic factor is PEDF
(Farnoodian et al., 2017). Furthermore, there is a mutually
opposite regulation between these two factors: VEGF can induce
MMP expression, which in turn will degrade retinal PEDF
(Notari et al., 2005). In our analysis, we found a fast upregulation
of VEGF expression within 6 h of PA. This was to be expected
since VEGF is transactivated by HIF-1 transcription factor,
which rapidly signals to the nucleus under hypoxic conditions
(Kurihara et al., 2014). That this upregulation was prevented
by MB treatment suggests a preventive antiangiogenic effect
for MB in the retina. Also, PEDF did not change in the PA
animals but its expression was very significantly elevated in the
PA animals that were treated with MB. This elevation of an
antiangiogenic molecule, together with the downregulation of
VEGF, may partly explain the protective effect of MB on retinal
morphology and physiology.
Another aspect needed for angiogenesis and retinal
thickening is extracellular matrix remodeling. Dynamic changes
in the connective tissue depend on the activity of many proteases,
including MMPs and, in particular, gelatinases (Jabło ńska-
Trypu ć et al., 2016). Interestingly, MMP2 did not respond to
either PA or the treatment with MB but MMP9 expression
increased following PA. It has been shown that hypoxia (Li
and Zheng, 2017) and iNOS (Anavi et al., 2015) can upregulate
MMP9 expression under some conditions, and that MMP9 is a
proangiogenic factor (Djordjevic et al., 2018), so the increased
expression of MMP9 following PA may contribute to enhanced
angiogenesis and the thickening of the IR we observed in these
animals. Also, MMP9 has been implicated in the degradation of
PEDF in the retina (Notari et al., 2005), thus further implicating
this protease in angiogenesis regulation. The fact that MB was
able to completely prevent MMP9 overexpression, probably
through blockade of excessive NO availability, further supports
the protective role of this chemical.
In summary, MB represents an effective treatment to reduce
the physiological, morphological, and molecular telltales of
retinal degeneration following episodes of PA and, given its safety
profile and low cost, it could be used as an alternative therapy to
hypothermia in regions of the world where that intervention may
be unavailable.
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